CDK2-IN-26

• Description:

  CDK2-IN-26 (compound 9) is a potent inhibitor of CDK2[1].

• UNSPSC:

  12352005

• Target:

  CDK

• Type:

  Reference compound

• Related Pathways:

  Cell Cycle/DNA Damage

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/cdk2-in-26.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(C1=CC(OCC(F)F)=NN1C)NC2=CC([C@H](OC3)C[C@H]3OC(NC45CC(C5)C4)=O)=NN2

• Molecular Formula:

  C20H24F2N6O5

• Molecular Weight:

  466.44

• References & Citations:

  [1]Relay Therapeutics, Inc. Heterocyclic amides as CDK inhibitors and their preparation, pharmaceutical compositions and use in the treatment of cancer. World Intellectual Property Organization, WO2023154426 A1 2023-08-17

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• Isoform:

  CDK2

• CAS Number:

  [2821777-43-7]